130 related articles for article (PubMed ID: 35943241)
1. Sex-based Difference in Response to Recombinant Human Bone Morphogenetic Protein-2 in a Rat Posterolateral Fusion Model.
Foley JP; Fred EJ; Minardi S; Yamaguchi JT; Greene AC; Furman AA; Lyons JG; Paul JT; Nandurkar TS; Blank KR; Havey RM; Muriuki M; Patwardhan AG; Hsu WK; Stock SR; Hsu EL
Spine (Phila Pa 1976); 2022 Dec; 47(23):1627-1636. PubMed ID: 35943241
[TBL] [Abstract][Full Text] [Related]
2. Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion.
Cottrill E; Pennington Z; Wolf MT; Dirckx N; Ehresman J; Perdomo-Pantoja A; Rajkovic C; Lin J; Maestas DR; Mageau A; Lambrechts D; Stewart V; Sciubba DM; Theodore N; Elisseeff JH; Witham T
J Neurosurg Spine; 2023 Jul; 39(1):113-121. PubMed ID: 37021767
[TBL] [Abstract][Full Text] [Related]
3. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
[TBL] [Abstract][Full Text] [Related]
4. The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.
Mendoza MC; Sonn KA; Kannan AS; Bellary SS; Mitchell SM; Singh G; Park C; Yun C; Stock SR; Hsu EL; Hsu WK
J Neurosurg Spine; 2016 Aug; 25(2):147-53. PubMed ID: 27035510
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow enhances the performance of rhBMP-2 in spinal fusion: a rodent model.
Bae HW; Zhao L; Kanim LE; Wong P; Marshall D; Delamarter RB
J Bone Joint Surg Am; 2013 Feb; 95(4):338-47. PubMed ID: 23426768
[TBL] [Abstract][Full Text] [Related]
6. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
[TBL] [Abstract][Full Text] [Related]
7. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
[TBL] [Abstract][Full Text] [Related]
8. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
[TBL] [Abstract][Full Text] [Related]
9. Osteoinductivity and biomechanical assessment of a 3D printed demineralized bone matrix-ceramic composite in a rat spine fusion model.
Plantz MA; Minardi S; Lyons JG; Greene AC; Ellenbogen DJ; Hallman M; Yamaguchi JT; Jeong S; Yun C; Jakus AE; Blank KR; Havey RM; Muriuki M; Patwardhan AG; Shah RN; Hsu WK; Stock SR; Hsu EL
Acta Biomater; 2021 Jun; 127():146-158. PubMed ID: 33831576
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
[TBL] [Abstract][Full Text] [Related]
11. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
[TBL] [Abstract][Full Text] [Related]
12. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
[TBL] [Abstract][Full Text] [Related]
13. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
[TBL] [Abstract][Full Text] [Related]
14. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
[TBL] [Abstract][Full Text] [Related]
15. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area.
Ames CP; Smith JS; Preul MC; Crawford NR; Kim GE; Nottmeier E; Chamberlain R; Speiser B; Sonntag VK; Dickman CA
Spine (Phila Pa 1976); 2005 Dec; 30(23):2585-92. PubMed ID: 16319743
[TBL] [Abstract][Full Text] [Related]
17. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
[TBL] [Abstract][Full Text] [Related]
18. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
[TBL] [Abstract][Full Text] [Related]
19. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the osteogenesis and fusion rates between activin A/BMP-2 chimera (AB204) and rhBMP-2 in a beagle's posterolateral lumbar spine model.
Zheng GB; Yoon BH; Lee JH
Spine J; 2017 Oct; 17(10):1529-1536. PubMed ID: 28522401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
